FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family

Abstract Background Children with autism spectrum disorder (ASD) display impressive clinical heterogeneity, also involving treatment response. Genetic variants can contribute to explain this large interindividual phenotypic variability. Methods Array‐CGH (a‐CGH) and whole genome sequencing (WGS) wer...

Full description

Bibliographic Details
Main Authors: Francesca Cucinotta, Arianna Ricciardello, Laura Turriziani, Giorgia Calabrese, Marilena Briguglio, Maria Boncoddo, Fabiana Bellomo, Pasquale Tomaiuolo, Silvia Martines, Marianna Bruschetta, Francesca La Fauci Belponer, Tiziana Di Bella, Costanza Colombi, Marco Baccarin, Chiara Picinelli, Paola Castronovo, Carla Lintas, Roberto Sacco, Thomas Biederer, Barbara Kellam, Stephen W. Scherer, Antonio M. Persico
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.1373
_version_ 1797301163911020544
author Francesca Cucinotta
Arianna Ricciardello
Laura Turriziani
Giorgia Calabrese
Marilena Briguglio
Maria Boncoddo
Fabiana Bellomo
Pasquale Tomaiuolo
Silvia Martines
Marianna Bruschetta
Francesca La Fauci Belponer
Tiziana Di Bella
Costanza Colombi
Marco Baccarin
Chiara Picinelli
Paola Castronovo
Carla Lintas
Roberto Sacco
Thomas Biederer
Barbara Kellam
Stephen W. Scherer
Antonio M. Persico
author_facet Francesca Cucinotta
Arianna Ricciardello
Laura Turriziani
Giorgia Calabrese
Marilena Briguglio
Maria Boncoddo
Fabiana Bellomo
Pasquale Tomaiuolo
Silvia Martines
Marianna Bruschetta
Francesca La Fauci Belponer
Tiziana Di Bella
Costanza Colombi
Marco Baccarin
Chiara Picinelli
Paola Castronovo
Carla Lintas
Roberto Sacco
Thomas Biederer
Barbara Kellam
Stephen W. Scherer
Antonio M. Persico
author_sort Francesca Cucinotta
collection DOAJ
description Abstract Background Children with autism spectrum disorder (ASD) display impressive clinical heterogeneity, also involving treatment response. Genetic variants can contribute to explain this large interindividual phenotypic variability. Methods Array‐CGH (a‐CGH) and whole genome sequencing (WGS) were performed on a multiplex family with two small children diagnosed with ASD at 17 and 18 months of age. Both brothers received the same naturalistic intervention for one year according to the Early Start Denver Model (ESDM), applied by the same therapists, yielding dramatically different treatment outcomes. Results The older sibling came out of the autism spectrum, while the younger sibling displayed very little, in any, improvement. This boy was subsequently treated applying a structured Early Intensive Behavioral Intervention paired with Augmentative Alternative Communication, which yielded a partial response within another year. The ESDM nonresponsive child carries a novel maternally inherited 65 Kb deletion at chr. 13q32.2 spanning FARP1. Farp1 is a synaptic scaffolding protein, which plays a significant role in neural plasticity. Conclusion These results represent a paradigmatic example of the heuristic potential of genetic markers in predicting treatment response and possibly in supporting the targeted prescription of specific early intervention approaches.
first_indexed 2024-03-07T23:17:30Z
format Article
id doaj.art-fad1dd81389e4f15bb4c6f2937598d76
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-03-07T23:17:30Z
publishDate 2020-09-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-fad1dd81389e4f15bb4c6f2937598d762024-02-21T10:24:50ZengWileyMolecular Genetics & Genomic Medicine2324-92692020-09-0189n/an/a10.1002/mgg3.1373FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex familyFrancesca Cucinotta0Arianna Ricciardello1Laura Turriziani2Giorgia Calabrese3Marilena Briguglio4Maria Boncoddo5Fabiana Bellomo6Pasquale Tomaiuolo7Silvia Martines8Marianna Bruschetta9Francesca La Fauci Belponer10Tiziana Di Bella11Costanza Colombi12Marco Baccarin13Chiara Picinelli14Paola Castronovo15Carla Lintas16Roberto Sacco17Thomas Biederer18Barbara Kellam19Stephen W. Scherer20Antonio M. Persico21Interdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyDepartment of Psychiatry University of Michigan Ann Arbor MI USAMafalda Luce Center for Pervasive Developmental Disorders Milan ItalyMafalda Luce Center for Pervasive Developmental Disorders Milan ItalyMafalda Luce Center for Pervasive Developmental Disorders Milan ItalyService for Neurodevelopmental Disorders & Laboratory of Molecular Psychiatry and Neurogenetics University “Campus Bio‐Medico” Rome ItalyService for Neurodevelopmental Disorders & Laboratory of Molecular Psychiatry and Neurogenetics University “Campus Bio‐Medico” Rome ItalyDepartment of Neurology Yale University School of Medicine New Haven CT USAGenetics & Genome Biology Program Toronto CanadaGenetics & Genome Biology Program Toronto CanadaInterdepartmental Program "Autism 0‐90" "G. Martino" University Hospital of Messina Messina ItalyAbstract Background Children with autism spectrum disorder (ASD) display impressive clinical heterogeneity, also involving treatment response. Genetic variants can contribute to explain this large interindividual phenotypic variability. Methods Array‐CGH (a‐CGH) and whole genome sequencing (WGS) were performed on a multiplex family with two small children diagnosed with ASD at 17 and 18 months of age. Both brothers received the same naturalistic intervention for one year according to the Early Start Denver Model (ESDM), applied by the same therapists, yielding dramatically different treatment outcomes. Results The older sibling came out of the autism spectrum, while the younger sibling displayed very little, in any, improvement. This boy was subsequently treated applying a structured Early Intensive Behavioral Intervention paired with Augmentative Alternative Communication, which yielded a partial response within another year. The ESDM nonresponsive child carries a novel maternally inherited 65 Kb deletion at chr. 13q32.2 spanning FARP1. Farp1 is a synaptic scaffolding protein, which plays a significant role in neural plasticity. Conclusion These results represent a paradigmatic example of the heuristic potential of genetic markers in predicting treatment response and possibly in supporting the targeted prescription of specific early intervention approaches.https://doi.org/10.1002/mgg3.1373autism spectrum disorderbiomarkersFARP1neuronal plasticitytreatment outcome
spellingShingle Francesca Cucinotta
Arianna Ricciardello
Laura Turriziani
Giorgia Calabrese
Marilena Briguglio
Maria Boncoddo
Fabiana Bellomo
Pasquale Tomaiuolo
Silvia Martines
Marianna Bruschetta
Francesca La Fauci Belponer
Tiziana Di Bella
Costanza Colombi
Marco Baccarin
Chiara Picinelli
Paola Castronovo
Carla Lintas
Roberto Sacco
Thomas Biederer
Barbara Kellam
Stephen W. Scherer
Antonio M. Persico
FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
Molecular Genetics & Genomic Medicine
autism spectrum disorder
biomarkers
FARP1
neuronal plasticity
treatment outcome
title FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
title_full FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
title_fullStr FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
title_full_unstemmed FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
title_short FARP‐1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
title_sort farp 1 deletion is associated with lack of response to autism treatment by early start denver model in a multiplex family
topic autism spectrum disorder
biomarkers
FARP1
neuronal plasticity
treatment outcome
url https://doi.org/10.1002/mgg3.1373
work_keys_str_mv AT francescacucinotta farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT ariannaricciardello farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT lauraturriziani farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT giorgiacalabrese farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT marilenabriguglio farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT mariaboncoddo farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT fabianabellomo farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT pasqualetomaiuolo farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT silviamartines farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT mariannabruschetta farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT francescalafaucibelponer farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT tizianadibella farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT costanzacolombi farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT marcobaccarin farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT chiarapicinelli farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT paolacastronovo farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT carlalintas farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT robertosacco farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT thomasbiederer farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT barbarakellam farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT stephenwscherer farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily
AT antoniompersico farp1deletionisassociatedwithlackofresponsetoautismtreatmentbyearlystartdenvermodelinamultiplexfamily